Jack-Whelan.com is the company name of my Research Advocacy business focused on representing the patient's voice in several key focus areas in healthcare. Jack is a Research and Patient Advocate encouraging patients and caregivers to explore the emerging targeted chemotherapy available in Clinical Trials. These can be a safer and more effective when we use the information learned from genetics and genomics. The road to Personalized or Precision medicine is currently being constructed and the knowledge gained is a game changer for the healthcare industry. Jack is a credible, informative, fun event speaker, an associate member of American Association of Cancer Research (AACR), active in American Association of Clinical Oncology (ASCO), the Drug Information Association (DIA) and active volunteer in advocacy and legislative circles with Leukemia & Lymphoma Society and the International Waldenstrom's Macroglobulinemia Foundation. He is a member of Research Advocacy Network and Education Network to AdvanceClinical Trials (ENACCT). He has consulted with Investment firms, Biopharmaceutical companies, payors, providers, physicians and patients. See his personal LinkedIn page and website.
Looking for a particular Jack-Whelan.com employee's phone or email?
The Jack-Whelan.com annual revenue was $1 million in 2026.
1 people are employed at Jack-Whelan.com.
Jack-Whelan.com is based in Andover, Massachusetts.
The NAICS codes for Jack-Whelan.com are [32541, 32, 3254, 325].
The SIC codes for Jack-Whelan.com are [283, 28].